 Lisa Spencer
Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophils | 36 | 2026 | 316 | 8.570 |
Why?
| | Allergens | 5 | 2026 | 386 | 2.180 |
Why?
| | Eosinophilia | 10 | 2024 | 224 | 2.140 |
Why?
| | Enteritis | 7 | 2024 | 105 | 2.130 |
Why?
| | Gastritis | 7 | 2024 | 117 | 2.010 |
Why?
| | Immunity, Innate | 7 | 2026 | 835 | 1.770 |
Why?
| | Hypersensitivity | 3 | 2022 | 254 | 1.470 |
Why?
| | Eosinophilic Esophagitis | 4 | 2024 | 332 | 1.370 |
Why?
| | Intestine, Small | 2 | 2021 | 167 | 1.040 |
Why?
| | Food Hypersensitivity | 2 | 2026 | 164 | 0.980 |
Why?
| | Adaptive Immunity | 2 | 2025 | 167 | 0.950 |
Why?
| | Antigen Presentation | 2 | 2018 | 208 | 0.940 |
Why?
| | Duodenum | 1 | 2026 | 77 | 0.920 |
Why?
| | Lymphoid Tissue | 1 | 2025 | 78 | 0.890 |
Why?
| | Receptor, Notch2 | 1 | 2024 | 15 | 0.850 |
Why?
| | Lymphocytes | 2 | 2026 | 376 | 0.830 |
Why?
| | Intestines | 3 | 2024 | 354 | 0.830 |
Why?
| | Duodenitis | 1 | 2022 | 6 | 0.740 |
Why?
| | CD11 Antigens | 1 | 2022 | 30 | 0.710 |
Why?
| | Receptors, Notch | 2 | 2015 | 90 | 0.690 |
Why?
| | Signal Transduction | 7 | 2024 | 5224 | 0.680 |
Why?
| | Cytokines | 7 | 2017 | 2069 | 0.630 |
Why?
| | Mucous Membrane | 1 | 2020 | 128 | 0.590 |
Why?
| | Integrins | 1 | 2019 | 90 | 0.570 |
Why?
| | Cell Degranulation | 7 | 2017 | 40 | 0.570 |
Why?
| | Flow Cytometry | 5 | 2021 | 1165 | 0.560 |
Why?
| | Th2 Cells | 2 | 2010 | 175 | 0.550 |
Why?
| | T-Lymphocytes | 1 | 2025 | 1998 | 0.510 |
Why?
| | Receptors, IgG | 1 | 2016 | 77 | 0.480 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2015 | 161 | 0.470 |
Why?
| | Adrenal Cortex Hormones | 1 | 2019 | 484 | 0.470 |
Why?
| | Intestinal Mucosa | 2 | 2021 | 675 | 0.460 |
Why?
| | Immunity, Humoral | 1 | 2016 | 118 | 0.450 |
Why?
| | Environmental Exposure | 1 | 2020 | 578 | 0.450 |
Why?
| | Lung | 3 | 2026 | 4116 | 0.450 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2015 | 30 | 0.440 |
Why?
| | Animals | 21 | 2026 | 38101 | 0.430 |
Why?
| | Immunoglobulin E | 1 | 2016 | 315 | 0.430 |
Why?
| | Diet Therapy | 1 | 2015 | 36 | 0.430 |
Why?
| | Mice | 12 | 2026 | 18355 | 0.420 |
Why?
| | Diet, Reducing | 1 | 2015 | 91 | 0.420 |
Why?
| | Extracellular Traps | 3 | 2019 | 52 | 0.390 |
Why?
| | Phenotype | 3 | 2022 | 3170 | 0.390 |
Why?
| | Homeostasis | 3 | 2025 | 644 | 0.390 |
Why?
| | Secretory Vesicles | 5 | 2016 | 24 | 0.390 |
Why?
| | Biomarkers | 3 | 2022 | 4302 | 0.390 |
Why?
| | Mice, Inbred C57BL | 6 | 2026 | 5992 | 0.380 |
Why?
| | Ovalbumin | 2 | 2026 | 194 | 0.350 |
Why?
| | Postpartum Period | 1 | 2015 | 373 | 0.350 |
Why?
| | Organ Specificity | 3 | 2020 | 309 | 0.350 |
Why?
| | Interleukin-4 | 3 | 2008 | 207 | 0.340 |
Why?
| | Pregnancy Outcome | 1 | 2015 | 504 | 0.340 |
Why?
| | Chemokine CCL11 | 6 | 2016 | 25 | 0.320 |
Why?
| | Cytoplasmic Granules | 5 | 2017 | 60 | 0.290 |
Why?
| | Asthma | 1 | 2021 | 1797 | 0.290 |
Why?
| | Autocrine Communication | 1 | 2009 | 38 | 0.290 |
Why?
| | Galectins | 2 | 2019 | 26 | 0.280 |
Why?
| | Inflammation | 5 | 2022 | 2884 | 0.280 |
Why?
| | Immunophenotyping | 3 | 2020 | 322 | 0.280 |
Why?
| | Humans | 41 | 2025 | 145783 | 0.270 |
Why?
| | Th1 Cells | 1 | 2008 | 139 | 0.270 |
Why?
| | Leukocytes | 2 | 2021 | 296 | 0.260 |
Why?
| | Ligands | 1 | 2009 | 668 | 0.250 |
Why?
| | Receptors, Cytokine | 1 | 2006 | 36 | 0.230 |
Why?
| | Cell Differentiation | 3 | 2015 | 2050 | 0.230 |
Why?
| | Mice, Knockout | 3 | 2024 | 3130 | 0.220 |
Why?
| | Mice, Transgenic | 4 | 2018 | 2191 | 0.200 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2024 | 1217 | 0.200 |
Why?
| | Bile Acids and Salts | 1 | 2024 | 163 | 0.200 |
Why?
| | Cells, Cultured | 7 | 2016 | 4151 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 849 | 0.180 |
Why?
| | Allergy and Immunology | 2 | 2024 | 43 | 0.180 |
Why?
| | Crystallization | 2 | 2019 | 136 | 0.180 |
Why?
| | Rare Diseases | 2 | 2024 | 116 | 0.180 |
Why?
| | CD11c Antigen | 1 | 2022 | 40 | 0.180 |
Why?
| | Cell Movement | 1 | 2026 | 963 | 0.170 |
Why?
| | Myositis | 1 | 2021 | 57 | 0.160 |
Why?
| | Leukocyte Count | 1 | 2021 | 318 | 0.160 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 560 | 0.160 |
Why?
| | Tetraspanin 30 | 3 | 2016 | 10 | 0.150 |
Why?
| | Cell Separation | 1 | 2021 | 306 | 0.150 |
Why?
| | Mice, Inbred BALB C | 4 | 2016 | 1261 | 0.150 |
Why?
| | Rheumatology | 1 | 2021 | 133 | 0.150 |
Why?
| | Cell Death | 2 | 2018 | 382 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2020 | 344 | 0.140 |
Why?
| | Exocytosis | 2 | 2016 | 85 | 0.140 |
Why?
| | Immunoglobulin G | 1 | 2022 | 892 | 0.130 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 17 | 0.130 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2021 | 269 | 0.130 |
Why?
| | Antigen-Presenting Cells | 1 | 2018 | 159 | 0.130 |
Why?
| | Fluorescent Antibody Technique | 1 | 2018 | 365 | 0.130 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1049 | 0.130 |
Why?
| | Eosinophil Granule Proteins | 2 | 2007 | 15 | 0.120 |
Why?
| | Disease Models, Animal | 4 | 2024 | 4568 | 0.120 |
Why?
| | Advisory Committees | 1 | 2018 | 229 | 0.120 |
Why?
| | Health Services Needs and Demand | 1 | 2018 | 280 | 0.120 |
Why?
| | Antigens | 2 | 2016 | 348 | 0.120 |
Why?
| | Lung Diseases | 2 | 2020 | 782 | 0.120 |
Why?
| | Microscopy, Electron, Transmission | 6 | 2015 | 156 | 0.120 |
Why?
| | Sarcoidosis | 1 | 2018 | 163 | 0.110 |
Why?
| | Gastroenterology | 1 | 2018 | 191 | 0.110 |
Why?
| | Receptor, Notch1 | 1 | 2015 | 63 | 0.110 |
Why?
| | Eosinophil Major Basic Protein | 3 | 2009 | 7 | 0.110 |
Why?
| | Respiratory Hypersensitivity | 1 | 2015 | 65 | 0.110 |
Why?
| | Models, Animal | 1 | 2016 | 392 | 0.110 |
Why?
| | Adoptive Transfer | 1 | 2015 | 200 | 0.110 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2015 | 78 | 0.110 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2601 | 0.110 |
Why?
| | Inflammation Mediators | 1 | 2017 | 507 | 0.110 |
Why?
| | Female | 8 | 2026 | 79045 | 0.100 |
Why?
| | Lung Diseases, Interstitial | 1 | 2021 | 664 | 0.100 |
Why?
| | Decision Support Systems, Clinical | 1 | 2017 | 273 | 0.100 |
Why?
| | Anti-HIV Agents | 1 | 2021 | 912 | 0.100 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2021 | 692 | 0.100 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2019 | 992 | 0.100 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 308 | 0.100 |
Why?
| | Decision Support Techniques | 1 | 2017 | 480 | 0.100 |
Why?
| | Microscopy, Immunoelectron | 3 | 2009 | 43 | 0.090 |
Why?
| | Protein Transport | 3 | 2016 | 442 | 0.090 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2013 | 224 | 0.090 |
Why?
| | Life Style | 1 | 2015 | 486 | 0.090 |
Why?
| | Ribonucleases | 1 | 2012 | 48 | 0.090 |
Why?
| | Machine Learning | 1 | 2017 | 587 | 0.090 |
Why?
| | Detergents | 1 | 2011 | 43 | 0.090 |
Why?
| | Chemokines, CC | 3 | 2006 | 33 | 0.080 |
Why?
| | Cytoplasm | 2 | 2016 | 254 | 0.080 |
Why?
| | Body Weight | 1 | 2015 | 972 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1478 | 0.080 |
Why?
| | Health | 1 | 2010 | 82 | 0.080 |
Why?
| | Helminthiasis | 1 | 2010 | 11 | 0.080 |
Why?
| | Helminths | 1 | 2010 | 11 | 0.080 |
Why?
| | Disease | 1 | 2010 | 96 | 0.080 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2011 | 364 | 0.080 |
Why?
| | Algorithms | 1 | 2017 | 1851 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2017 | 2805 | 0.080 |
Why?
| | Receptors, Immunologic | 1 | 2010 | 209 | 0.070 |
Why?
| | Centrifugation, Density Gradient | 1 | 2009 | 36 | 0.070 |
Why?
| | Cell Fractionation | 1 | 2009 | 50 | 0.070 |
Why?
| | Jagged-2 Protein | 1 | 2009 | 1 | 0.070 |
Why?
| | Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2009 | 4 | 0.070 |
Why?
| | Serrate-Jagged Proteins | 1 | 2009 | 27 | 0.070 |
Why?
| | Pregnancy Complications | 1 | 2015 | 603 | 0.070 |
Why?
| | Hypereosinophilic Syndrome | 2 | 2024 | 8 | 0.070 |
Why?
| | Endopeptidases | 1 | 2009 | 80 | 0.070 |
Why?
| | Receptors, Chemokine | 2 | 2006 | 48 | 0.070 |
Why?
| | Organelles | 1 | 2008 | 55 | 0.070 |
Why?
| | Interferon-gamma | 2 | 2008 | 784 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1752 | 0.070 |
Why?
| | Peptide Hydrolases | 1 | 2009 | 105 | 0.070 |
Why?
| | Immunity, Cellular | 1 | 2010 | 274 | 0.070 |
Why?
| | DNA-Binding Proteins | 1 | 2015 | 1482 | 0.070 |
Why?
| | Interleukin-13 | 1 | 2008 | 146 | 0.070 |
Why?
| | Incidence | 1 | 2015 | 2934 | 0.070 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 221 | 0.060 |
Why?
| | Quality of Life | 1 | 2020 | 3211 | 0.060 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 376 | 0.060 |
Why?
| | Transcription Factors | 1 | 2015 | 1736 | 0.060 |
Why?
| | Retrospective Studies | 2 | 2022 | 17330 | 0.060 |
Why?
| | Receptors, Interleukin-4 | 1 | 2006 | 16 | 0.060 |
Why?
| | Receptors, CCR3 | 1 | 2006 | 7 | 0.060 |
Why?
| | DNA | 1 | 2013 | 1437 | 0.060 |
Why?
| | Receptors, Interleukin-6 | 1 | 2006 | 48 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2009 | 457 | 0.060 |
Why?
| | Cell Survival | 1 | 2009 | 1104 | 0.060 |
Why?
| | HIV Infections | 1 | 2021 | 3195 | 0.060 |
Why?
| | Intracellular Membranes | 1 | 2005 | 77 | 0.060 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2008 | 411 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 821 | 0.060 |
Why?
| | Avidin | 1 | 2005 | 2 | 0.060 |
Why?
| | Skin | 2 | 2018 | 754 | 0.050 |
Why?
| | Sepharose | 1 | 2005 | 32 | 0.050 |
Why?
| | Child | 2 | 2022 | 22740 | 0.050 |
Why?
| | Gels | 1 | 2005 | 85 | 0.050 |
Why?
| | Ileitis | 1 | 2024 | 33 | 0.050 |
Why?
| | Staining and Labeling | 1 | 2005 | 153 | 0.050 |
Why?
| | Biological Therapy | 1 | 2024 | 28 | 0.050 |
Why?
| | Cholangitis, Sclerosing | 1 | 2024 | 61 | 0.050 |
Why?
| | Ileum | 1 | 2024 | 112 | 0.050 |
Why?
| | Congresses as Topic | 1 | 2024 | 224 | 0.050 |
Why?
| | Exercise | 1 | 2015 | 2205 | 0.050 |
Why?
| | Antibodies | 1 | 2005 | 397 | 0.050 |
Why?
| | Brugia malayi | 1 | 2002 | 1 | 0.050 |
Why?
| | Brugia pahangi | 1 | 2002 | 1 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2024 | 288 | 0.050 |
Why?
| | Filariasis | 1 | 2002 | 3 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2009 | 1166 | 0.050 |
Why?
| | Peritoneal Cavity | 1 | 2002 | 30 | 0.050 |
Why?
| | Cell Membrane | 2 | 2018 | 709 | 0.040 |
Why?
| | Langerhans Cells | 1 | 2001 | 12 | 0.040 |
Why?
| | Dermis | 1 | 2001 | 31 | 0.040 |
Why?
| | Pregnancy | 1 | 2015 | 7216 | 0.040 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2001 | 88 | 0.040 |
Why?
| | Biological Transport | 2 | 2016 | 424 | 0.040 |
Why?
| | Obesity | 1 | 2015 | 3118 | 0.040 |
Why?
| | Emtricitabine | 1 | 2021 | 210 | 0.040 |
Why?
| | Protein Binding | 1 | 2006 | 2240 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 125 | 0.040 |
Why?
| | United States | 3 | 2024 | 16126 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1723 | 0.030 |
Why?
| | Brefeldin A | 2 | 2008 | 8 | 0.030 |
Why?
| | Platelet Membrane Glycoproteins | 2 | 2009 | 31 | 0.030 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 148 | 0.030 |
Why?
| | Joint Diseases | 1 | 2018 | 65 | 0.030 |
Why?
| | Abdomen | 1 | 2018 | 142 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2017 | 318 | 0.030 |
Why?
| | Eye | 1 | 2018 | 112 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2017 | 292 | 0.030 |
Why?
| | Genetic Markers | 1 | 2017 | 338 | 0.030 |
Why?
| | Europe | 1 | 2018 | 421 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 644 | 0.030 |
Why?
| | Eye Diseases | 1 | 2018 | 97 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 2018 | 450 | 0.030 |
Why?
| | Skin Diseases | 1 | 2018 | 152 | 0.030 |
Why?
| | Liver | 1 | 2024 | 1899 | 0.030 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2015 | 9 | 0.030 |
Why?
| | Granulocyte Precursor Cells | 1 | 2015 | 9 | 0.030 |
Why?
| | X-Box Binding Protein 1 | 1 | 2015 | 16 | 0.030 |
Why?
| | Adult | 2 | 2018 | 40881 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2018 | 509 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 610 | 0.030 |
Why?
| | Endoribonucleases | 1 | 2015 | 77 | 0.030 |
Why?
| | Acute Disease | 1 | 2018 | 1036 | 0.030 |
Why?
| | Oxygen | 1 | 2020 | 981 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 118 | 0.030 |
Why?
| | Health Personnel | 1 | 2021 | 757 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2015 | 319 | 0.030 |
Why?
| | Antigens, CD | 2 | 2009 | 558 | 0.030 |
Why?
| | Male | 5 | 2024 | 73010 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 979 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 2000 | 0.020 |
Why?
| | Genotype | 1 | 2018 | 1857 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2015 | 741 | 0.020 |
Why?
| | Extracellular Space | 1 | 2013 | 117 | 0.020 |
Why?
| | Cell-Free System | 1 | 2012 | 53 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2011 | 68 | 0.020 |
Why?
| | Triiodobenzoic Acids | 1 | 2009 | 6 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2009 | 69 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2009 | 73 | 0.020 |
Why?
| | Registries | 1 | 2017 | 2410 | 0.020 |
Why?
| | Proteoglycans | 1 | 2009 | 112 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2028 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1777 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 408 | 0.020 |
Why?
| | Cell Compartmentation | 1 | 2007 | 52 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 239 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2007 | 414 | 0.020 |
Why?
| | Chemokines | 1 | 2007 | 217 | 0.020 |
Why?
| | Blotting, Western | 1 | 2008 | 1184 | 0.010 |
Why?
| | Chemotactic Factors, Eosinophil | 1 | 2005 | 7 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2009 | 1368 | 0.010 |
Why?
| | Chemokine CCL5 | 1 | 2005 | 40 | 0.010 |
Why?
| | Platelet Activating Factor | 1 | 2005 | 45 | 0.010 |
Why?
| | Forecasting | 1 | 2007 | 390 | 0.010 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2005 | 48 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2011 | 1146 | 0.010 |
Why?
| | Infant | 1 | 2017 | 10091 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 11868 | 0.010 |
Why?
| | Molting | 1 | 2002 | 9 | 0.010 |
Why?
| | Immunocompetence | 1 | 2002 | 46 | 0.010 |
Why?
| | Chemokine CCL20 | 1 | 2001 | 5 | 0.010 |
Why?
| | Receptors, CCR6 | 1 | 2001 | 4 | 0.010 |
Why?
| | Macrophage Inflammatory Proteins | 1 | 2001 | 11 | 0.010 |
Why?
| | Granuloma | 1 | 2002 | 97 | 0.010 |
Why?
| | Imaging, Three-Dimensional | 1 | 2005 | 583 | 0.010 |
Why?
| | Mice, SCID | 1 | 2002 | 369 | 0.010 |
Why?
| | Chemotaxis | 1 | 2001 | 122 | 0.010 |
Why?
| | Endocytosis | 1 | 2001 | 168 | 0.010 |
Why?
| | Models, Biological | 1 | 2007 | 1764 | 0.010 |
Why?
| | Cell Division | 1 | 2001 | 757 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1568 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 22577 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2001 | 1133 | 0.010 |
Why?
| | Aged | 1 | 2018 | 26217 | 0.010 |
Why?
| | Stem Cells | 1 | 2001 | 630 | 0.010 |
Why?
| | Middle Aged | 1 | 2018 | 36309 | 0.010 |
Why?
| | Macrophages | 1 | 2002 | 1507 | 0.010 |
Why?
|
|
Spencer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|